Skip to content
← Full study record

NCT01242267 · MORE INFO

Limitations, agreements, and source contact

Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT · Source last updated 2026-04-02

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
Joshua.Zenreich@hmhn.org
organization
Hackensack Meridan Health
phone
5519964248
title
Joshua Zenreich
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
Joshua.Zenreich@hmhn.org
organization
Hackensack Meridan Health
phone
5519964248
title
Joshua Zenreich

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice